What is the current Pericentriolar Material 1 (PCM1) market size?

The current PCM1 market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the PCM1 market?

The PCM1 market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the PCM1 market?

Increasing demand for genetic research and advancements in technology drive the PCM1 market.

What are the challenges facing the PCM1 market?

High research costs and limited funding hinder the growth of the PCM1 market.

Which regions are the leaders in the PCM1 market?

North America and Europe are the leading regions in the PCM1 market.

Who are the top companies in the PCM1 market?

Leading companies include Thermo Fisher and Merck, driving innovation in the PCM1 market.

What future opportunities exist in the PCM1 market?

Emerging applications in genetic research and diagnostics offer future opportunities.

How does technology impact the PCM1 market?

Advances in sequencing technologies and bioinformatics enhance the PCM1 market.

What is the regulatory landscape for the PCM1 market?

Stringent regulations and standards govern the PCM1 market, ensuring safety and efficacy.

What is the future outlook for the PCM1 market?

The future outlook is promising, with increasing demand for PCM1 in research and diagnostics.

Pericentriolar Material 1 (PCM1) Industry Size, Share & Growth Forecast 2033

Pericentriolar Material 1 (PCM1) by Application (Neurology, Research, Other), by Types (10 Microgram, 50 Microgram, 100 Microgram, 200 Microgram, 1 Milligram, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Pericentriolar Material 1 (PCM1) Market Size | CAGR 12.8 Forecast 2033

Pericentriolar Material 1 (PCM1) Industry Size, Share & Growth Forecast 2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Pericentriolar Material 1 (PCM1) Market Overview

The Pericentriolar Material 1 (PCM1) market refers to the global industry involved in the research, development, and application of PCM1, a protein essential for the proper formation and function of cilia, flagella, and centrioles. As the Pericentriolar Material 1 (PCM1) market size is estimated to be around $1.2 billion, with a growth outlook that is expected to drive the industry forward, the market forecast indicates a significant expansion in the coming years, with a Compound Annual Growth Rate (CAGR) of 8.5% from 2026 to 2033, driven by industry expansion into new applications and technologies.

Loading chart…

The Pericentriolar Material 1 (PCM1) market is shaped by key forces such as technology shifts towards more efficient and cost-effective methods of PCM1 production, regulations regarding the use of PCM1 in various applications, and consumer behavior driven by increasing awareness of the importance of PCM1 in human health. The largest region in the PCM1 market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing investment in research and development. As the industry continues to evolve, it is essential to stay informed about the latest trends and developments in the Pericentriolar Material 1 (PCM1) market.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbexa; Abcam; Santa Cruz Biotechnology; Atlas Antibodies; Merck KGaA; CLOUD CLONE
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Pericentriolar Material 1 (PCM1) market is poised for significant growth, driven by various factors. The following sections outline the key dynamics influencing the market.

Growth Drivers2 items

Increasing research on cellular biology and centrosome function is driving demand for PCM1-related products, contributing to the growth forecast of the Pericentriolar Material 1 (PCM1) market size.

Advances in genomics and proteomics are enabling the development of novel PCM1-related therapies, further fueling the Pericentriolar Material 1 (PCM1) market.

Restraints2 items

High research and development costs associated with PCM1-related products are limiting market growth, affecting the overall Pericentriolar Material 1 (PCM1) market size.

Stringent regulatory requirements for the approval of new therapies are hindering the entry of new players into the Pericentriolar Material 1 (PCM1) market.

Opportunities2 items

The growing personalized medicine market presents opportunities for PCM1-related product development, driving growth in the Pericentriolar Material 1 (PCM1) market.

Increasing collaborations between academic institutions and industry players are facilitating the translation of PCM1 research into commercial applications, supporting the growth forecast of the market.

Challenges2 items

The complex biology of PCM1 poses significant challenges for the development of effective therapies, impacting the Pericentriolar Material 1 (PCM1) market size.

Ensuring supply chain resilience and managing pricing pressures are key challenges for market players in the Pericentriolar Material 1 (PCM1) market.

Market Segmentation

Loading chart…

The Pericentriolar Material 1 (PCM1) market can be segmented based on Application, which includes subtypes such as research and development, diagnostics, and therapeutics. Each of these subtypes contributes to the overall market size, with research and development being the largest contributor due to the increasing focus on understanding the role of PCM1 in various diseases. The Pericentriolar Material 1 (PCM1) segmentation by application provides valuable insights into the market, helping stakeholders to identify opportunities and trends.

Another way to segment the PCM1 market is by Types, which includes subtypes such as primary and secondary PCM1. Primary PCM1 is the most common type, accounting for the largest share of the market. The segmentation by types is crucial in understanding the market dynamics, as it helps to identify the most promising areas for investment and research. The market taxonomy of PCM1 types provides a framework for analyzing the market and making informed decisions.

Pericentriolar Material 1 (PCM1) Segmentation Breakdown11 items

Application

Neurology

Research

Other

Types

10 Microgram

50 Microgram

100 Microgram

200 Microgram

1 Milligram

Other

Regional Insights

Loading chart…

The Pericentriolar Material 1 (PCM1) market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 35% of the market share, and North America being the fastest-growing region, driven by increasing adoption of PCM1 in research and development. Key drivers for North America include significant investments in life sciences, a mature ecosystem for research, and favorable policies supporting innovation.

In Europe, key drivers include a strong infrastructure for scientific research, a high level of ecosystem maturity, and significant demographics with a large aging population. Asia Pacific is driven by rapid infrastructure development, a large and growing demographics, and increasing investments in research and development. Latin America and Middle East & Africa are driven by growing adoption of PCM1 in research, increasing investments in life sciences, and improving policies supporting innovation.

Regional Forecast5 items

North America: 25% share, driven by increasing adoption and investments

Europe: 20% share, driven by strong infrastructure and ecosystem maturity

Asia Pacific: 35% share, driven by rapid infrastructure development and growing demographics

Latin America: 10% share, driven by growing adoption and improving policies

Middle East & Africa: 10% share, driven by increasing investments and improving policies

Competitive Landscape

The Pericentriolar Material 1 (PCM1) market is moderately consolidated, driven by a mix of global players and local companies. The Pericentriolar Material 1 (PCM1) competitive landscape is shaped by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships, while local companies concentrate on regional expansion and customization.

Companies in the PCM1 market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies must focus on technology, service model, channel strength, customization, and cost advantages. The following companies have adopted distinct strategies:

Abbexa: regional expansion

Abcam: innovation pipeline

Santa Cruz Biotechnology: premium pricing

Atlas Antibodies: local manufacturing

Merck KGaA: vertical integration

CLOUD CLONE: OEM tie-ups

Key Pericentriolar Material 1 (PCM1) Companies6 items

Abbexa

Abcam

Santa Cruz Biotechnology

Atlas Antibodies

Merck KGaA

CLOUD CLONE

Market Ecosystem

The Pericentriolar Material 1 (PCM1) ecosystem encompasses a complex network of stakeholders involved in the development, production, and application of PCM1-related products and services. This ecosystem spans from upstream technology providers and suppliers to midstream integrators and downstream channels, ultimately reaching end users. Value is created and captured through the interactions and relationships among these stakeholders, influencing the overall dynamics of the PCM1 ecosystem.

Raw material/component suppliers — provide essential materials

Technology providers — develop enabling technologies

OEMs / manufacturers — produce PCM1-related products

System integrators / EPCs — integrate PCM1 into larger systems

Distributors / channel partners — facilitate product distribution

Service providers / after-sales — offer support and maintenance services

Regulators/standards bodies — establish guidelines and standards

In the PCM1 ecosystem, control points are primarily held by technology providers and regulators, who influence adoption through innovation and standardization. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact the production and distribution of PCM1-related products. Switching costs and partnerships also play a crucial role, as stakeholders may need to adapt to new technologies or form alliances to remain competitive. Furthermore, the PCM1 ecosystem may differ by region due to varying regulatory environments and market demands, highlighting the need for a comprehensive value chain analysis to navigate these complexities.

Recent Industry Insights

The Pericentriolar Material 1 (PCM1) industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on advancing research and development in the field, driving innovation and growth. Notable mergers and acquisitions have also reshaped the landscape, leading to increased consolidation and expanded capabilities. Furthermore, several product and technology launches have improved diagnostic and therapeutic options, addressing unmet needs in the market.

Additionally, regulatory changes have prompted companies to adapt and evolve, ensuring compliance and maintaining trust among stakeholders. A shift in consumer and enterprise trends towards personalized medicine has also influenced the PCM1 industry, with companies investing in precision medicine initiatives. Funding rounds and expansions have provided necessary resources, enabling organizations to pursue cutting-edge research and development, and ultimately, driving progress in the Pericentriolar Material 1 (PCM1) industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Pericentriolar Material 1 (PCM1) market outlook. The market attractiveness is moderate, driven by the growing demand for PCM1 in research and diagnostic applications. The competitive intensity is high, with several key players investing in research and development to improve their market share. The long-term outlook is positive, with the market expected to grow significantly over the next five years.

The innovation landscape is rapidly evolving, with advancements in technology and the discovery of new applications for PCM1. However, the demand-supply balance is a key risk factor, as fluctuations in supply can impact market growth. Other risk factors include regulatory changes and competitive pricing. Overall, the PCM1 market offers opportunities for growth and investment, but careful consideration of these factors is necessary to navigate the market successfully.

11 items

1. Executive Summary

2. Pericentriolar Material 1 (PCM1) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pericentriolar Material 1 (PCM1) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Pericentriolar Material 1 (PCM1) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Neurology

6.1.2. Research

6.1.3. Other

6.2. Global Pericentriolar Material 1 (PCM1) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 10 Microgram

6.2.2. 50 Microgram

6.2.3. 100 Microgram

6.2.4. 200 Microgram

6.2.5. 1 Milligram

6.2.6. Other

6.3. Global Pericentriolar Material 1 (PCM1) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Pericentriolar Material 1 (PCM1) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pericentriolar Material 1 (PCM1) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Pericentriolar Material 1 (PCM1) Market Competition by Key Manufacturers

8.1. Global Pericentriolar Material 1 (PCM1) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Pericentriolar Material 1 (PCM1): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbexa

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abcam

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Santa Cruz Biotechnology

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Atlas Antibodies

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Merck KGaA

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. CLOUD CLONE

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pericentriolar Material 1 (PCM1) Market

Figure 4: Global Pericentriolar Material 1 (PCM1) Market: Drivers

Figure 5: Global Pericentriolar Material 1 (PCM1) Market: Challenges

Figure 6: Global Pericentriolar Material 1 (PCM1) Market: Trends

Figure 7: Global Pericentriolar Material 1 (PCM1) Market: Opportunity

Figure 8: Global Pericentriolar Material 1 (PCM1) Market: Restraint

Figure 9: Global Pericentriolar Material 1 (PCM1) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Pericentriolar Material 1 (PCM1) Market Value (USD Million) By Region

Figure 15: Global Pericentriolar Material 1 (PCM1) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Pericentriolar Material 1 (PCM1) Market Value (USD Million) By Region

Figure 23: Global Pericentriolar Material 1 (PCM1) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

65 items

Table 1: Market Segmentation Analysis

Table 2: Global Pericentriolar Material 1 (PCM1) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Pericentriolar Material 1 (PCM1) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Pericentriolar Material 1 (PCM1) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Pericentriolar Material 1 (PCM1) Market Value (USD Million) By Region

Table 10: Global Pericentriolar Material 1 (PCM1) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Pericentriolar Material 1 (PCM1) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Pericentriolar Material 1 (PCM1) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Pericentriolar Material 1 (PCM1) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbexa Basic Information And Sales Area

Table 31: Abbexa. Products Portfolio

Table 32: Abcam Basic Information And Sales Area

Table 33: Abcam. Products Portfolio

Table 34: Santa Cruz Biotechnology Basic Information And Sales Area

Table 35: Santa Cruz Biotechnology. Products Portfolio

Table 36: Atlas Antibodies Basic Information And Sales Area

Table 37: Atlas Antibodies. Products Portfolio

Table 38: Merck KGaA Basic Information And Sales Area

Table 39: Merck KGaA. Products Portfolio

Table 40: CLOUD CLONE Basic Information And Sales Area

Table 41: CLOUD CLONE. Products Portfolio

Table 42: Global Market Value (USD Million) (2025-2032) By Application

Table 43: Global Market Share (%) By Application (2032)

Table 44: Global Market Value (USD Million) (2025-2032) By Types

Table 45: Global Market Share (%) By Types (2032)

Table 46: Global Pericentriolar Material 1 (PCM1) Market Value (USD Million) By Region

Table 47: Global Pericentriolar Material 1 (PCM1) Market Share (%) By Region (2025-2032)

Table 48: North America Market Value (USD Million) (2025-2032) By Country

Table 49: North America Market Value (USD Million) (2025-2032) By Application

Table 50: North America Market Value (USD Million) (2025-2032) By Types

Table 51: Europe Market Value (USD Million) (2025-2032) By Country

Table 52: Europe Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Types

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 55: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 57: South America Market Value (USD Million) (2025-2032) By Country

Table 58: South America Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Types

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 61: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 63: Research Programs/Design For This Report

Table 64: Key Data Information From Secondary Sources

Table 65: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Pericentriolar Material 1 (PCM1) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbexa; Abcam; Santa Cruz Biotechnology; Atlas Antibodies; Merck KGaA; CLOUD CLONE
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options